Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration‐resistant prostate cancer-Reference-Cited by-同舟云学术

Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration‐resistant prostate cancer

Published:2021-10-21 Issue:2 Volume:82 Page:182-192
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Pilling Amanda¹^ORCID,Kim Sahn‐Ho²,Hwang Clara¹

Affiliation:

1. Department of Internal Medicine Henry Ford Health System, Henry Ford Cancer Institute Detroit Michigan USA

2. Department of Urology Henry Ford Health System Detroit Michigan USA

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24257

Reference36 articles.

1. Integrative clinical genomics of advanced prostate;Robinson D;Cancer Cell,2015

2. Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer

3. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

4. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

5. Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone‐refractory prostate cancer: scientific basis and design of Southwest Oncology Group Study 9916;Hussain M;Semin Oncol,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative Chinese-Western medicine strategy to overcome docetaxel resistance in prostate cancer;Journal of Ethnopharmacology;2024-09

2. Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment;Genes & Diseases;2023-11

3. Systematic pan-cancer analysis on the expression and role of regulator of chromatin condensation 1/small nucleolar RNA host gene 3/small nucleolar RNA host gene 12;Frontiers in Molecular Biosciences;2022-09-06

4. Smart dual responsive nanocarriers with reactive oxygen species amplification assisted synergistic chemotherapy against prostate cancer;Journal of Colloid and Interface Science;2022-09